5.51 USD
↘ 0.33 (5.74%)PRE MARKET (AS OF 09:28 AM EDT)
TransCode Therapeutics, Inc. Common Stock
RNAZNASDAQ • USD
Market: OPEN
Open?$5.60
High?$6.06
Low?$4.85
Prev. Close?$5.84
Volume?1.4K
Avg. Volume?92.0K
VWAP?$5.52
Rel. Volume?0.01x
Bid / Ask
Bid?$4.96 × 100
Ask?$6.75 × 100
Spread?$1.79
Midpoint?$5.86
Valuation & Ratios
Market Cap?5.5M
Shares Out?950.3K
Float?832.6K
Float %?90.8%
P/E Ratio?N/A
P/B Ratio?4.43
EPS?-$45.98
Dividend?0.00%
Ex-Dividend?N/A
Shares of TransCode Therapeutics, Inc. Common Stock (RNAZ) are trading at $5.51. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, RNAZ appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
Themes
Employees
12
Market Cap
4.8M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-07-09
Address
6 LIBERTY SQUARE
BOSTON, MA 02109
Phone: 857-301-6857
BOSTON, MA 02109
Phone: 857-301-6857
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?49
Piotroski F-Score?0/9Weak
Altman Z-Score?-1.57Distress
Confidence?51%Low
Short InterestModerate
Short % of Float?4.36%Low
Short Interest?36.3K
Days to Cover?4.1
Free Float832.6K
Avg Daily Volume8.9K
Settlement Date2026-05-15
Financial Health
Current Ratio?3.11Strong
Quick Ratio?3.11Strong
Cash Ratio?2.39Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.43FAIR▾
Peers100
S&P41
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.2CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-3,491.7%WEAK▾
S&P3
ROA?-27.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-21404249
Enterprise Value?$-7285690
Fundamentals ratios updated end of day